2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow lorecivivint: new trials by email Literature Review of lorecivivint trials Research Report on lorecivivint
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis Lorecivivint - Osteoarthritis of the Knee | Phase 3 | Terminated | Biosplice Therapeutics, Inc. | 72 | 2021-07-15 | 2026-03-31 |
| A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee Placebo, Lorecivivint - Osteoarthritis, Knee | Phase 3 | Terminated | Biosplice Therapeutics, Inc. | 276 | 2020-08-25 | 2026-03-24 |
Osteoarthritis (2) · Osteoarthritis, Knee (2)
Biosplice Therapeutics, Inc. (2)
United States (2)
Ismail Simsek, MD (1) · Yusuf Yazici, MD (1)